COVID-19: Nigeria battles slow vaccination as variants increase infections

Pfizer has found its booster shots to be more effective against the Delta variant

As Nigeria’s fate for vaccination hangs on the goodwill of countries with abundant vaccines, one main factor stands between the country and a fierce rage of the pandemic: the seeming absence of a yet virulent change in the COVID-19 virus. It would appear that despite also detecting some of the

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```